Past Event

Ensuring Access to Effective Patient Medication Information

Consumers and patients need information about their medications that is accurate, balanced and delivered in an easily understood format. Unfortunately, recent studies have shown that current systems for delivering prescriptions to consumers consistently fail to fulfill the need for pertinent details.

On October 12, the Engelberg Center for Health Care Reform at Brookings hosted a public forum to discuss strategies for ensuring that patients have access to effective patient medication information (PMI). Through a series of panel discussions, key stakeholders explored patients’ expectations for this information and how they access the details and warnings, along with feasible solutions for delivering higher-quality information to patients.

After each panel, speakers took audience questions.

Agenda

Welcome, Overview, Key Elements of Effective PMI

D

Janet Woodcock

Director, Center for Drug Evaluation and Research - US Food and Drug Administration

9:25 a.m. -- Session I: FDA and Patient Medication Information – The Path Forward

D

Rachel Behrman

Director, Office of Medical Policy, Center for Drug Evaluation and Research

O

Amie O’Donoghue

Office of Medical Policy, Center for Drug Evaluation and Research, FDA

10:20 a.m. -- Session II: Patient Perspectives – Making PMI More Effective

D

Doris Peter

Director, Health Ratings Center - Consumer Health Choices

A

Nancy Hughes

Assistant Vice President of Communications and Marketing, National Health Council

S

Vanessa Cajina

Statewide Policy Analyst, California Immigrant Policy Center

12:45 p.m. -- Session III: Effective PMI – The Roles of Manufacturers and PMI Vendors

V

Tom Bizarro

Vice President, Health Policy and Industry Relations, First DataBank

M

Marissa Craddock

Manager, Labeling, Advertising, and Promotional Materials, Roxane Laboratories, Inc.

2:25 p.m. -- Session IV: Effective Distribution of PMI

S

Kate Berry

Senior Vice President, Strategy and Innovation, Surescripts

A

Will Lockwood

Assistant to the Executive Director, American Society for Automation in Pharmacy

S

John Coster

Senior Vice President, Government Affairs, National Community Pharmacists Association

V

Russell Teagarden

Vice President, Clinical Practices & Therapeutics, Medco Health Solutions, Inc.

3:50 p.m. -- Recap and Closing Remarks

D

Rachel Behrman

Director, Office of Medical Policy, Center for Drug Evaluation and Research

More Information

Contact
(202) 797-6105
Get a weekly events calendar from Brookings

More